Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SWAP-AC: Switching DAPT to Rivaroxaban DPI in CAD
NCT04006288Phase 4Completed
- Sponsor
- University of Florida
- Start
- Sep 2019
- Primary completion
- Jan 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of rivaroxaban in coronary artery disease (CAD), sponsored by University of Florida. Started Sep 2019; status: completed.
02
Drugs
rivaroxaban
03
Conditions
coronary artery disease (CAD)
Beyond the preview
Go deeper on NCT04006288.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04006288.